The U.S. Food and Drug Administration (FDA) has approved Symdeko (ivacaftor/tezacaftor tablets and ivacaftor tablets) for treating the underlying cause
Category: Headache
Biktarvy for treating HIV-1 infection
The U.S. Food and Drug Administration (FDA) has approved Biktarvy (bictegravir 50mg/emtricitabine 200mg/tenofovir alafenamide 25mg, BIC/FTC/TAF), a once-daily single tablet
Drug for breast cancer gene
The U.S. Food and Drug Administration on Friday approved drug for treating metastatic breast cancers linked to the BRCA gene
Clenpiq for Colonoscopy Prep
Food and Drug Administration FDA has granted approval of Clenpiq (sodium picosulfate, magnesium oxide, and anhydrous citric acid) oral solution
Juluca for treating virologically suppressed HIV-1 Infection
FDA Approves Juluca (dolutegravir and rilpivirine) for the maintenance and treatment of virologically suppressed HIV-1 Infection. This is the first
Fasenra for treating severe Eosinophilic Asthma
The US Food and Drug Administration has approved Fasenra (benralizumab) for the add-on maintenance treatment of patients with severe asthma
Cinvanti for treating chemotherapy – induced nausea and vomiting
The U.S. Food and Drug Administration has approved Cinvanti (aprepitant) injectable emulsion, for intravenous infusion. Cinvanti is a substance P/neurokinin-1
Fluticasone for nose congestion
Fluticasone is a steroid, it prevents the release of substances in the body that cause inflammation. Fluticasone nasal is used
Mvasi drug for cancer treatment
Mvasi is the first biosimilar approved for the treatment of multiple types of cancer. The is approved for the treatment
Vabomere for treatment of urinary tract infection
Vabomere drug for treating complicated urinary tract infections cuticles, including a type of kidney infection, pyelonephritis, caused by specific bacteria.
